pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Sep 14·1 min read
save

Biopharma firms urged to boost visibility with podcasts, webinars and thought-leadership programs

Sep 14, 2026·read at BioSpace ↗Neutral

The guide released by BioSpace Insights outlines how biopharma communication teams can use emerging channels to raise their profile.

It notes that while traditional media remains important, podcasts, webinars, whitepapers and expert-led content allow deeper engagement with specialized audiences.

The report offers practical recommendations for public-relations agencies, corporate communications and commercial marketers on selecting formats, targeting audiences and measuring business impact.

It emphasizes that thought leadership is now a strategic priority for generating leads and influencing decision-makers across the life-science ecosystem.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Report: The Insider's Guide to Thought Leadership in Biopharma”

read at BioSpace ↗
259 words · retrieved Sep 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 5h agoAfter 2 patient deaths and cell therapy durability concerns, Artiva cuts 94% of workforceBioSpace
  • 5h agoTeva closing New Jersey manufacturing facility, laying off 61 employeesBioSpace
  • 6h agoEMSO 2026: Incyte a ‘firm contender’ in G12D pancreatic cancer race as early candidate shinesBioSpace
  • 6h agoAlphabet’s GV is one of biotech’s most influential corporate investorsBioSpace
  • 7h agoNovartis faces $1.9B hit from Avidity fail but maintains confidence in $12B buyBioSpace